We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effect of Repeated Exposures to Compressed Air on Patients With AIDS (DANET1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00444847
Recruitment Status : Withdrawn
First Posted : March 8, 2007
Last Update Posted : July 27, 2017
Information provided by:
Designed Altobaric Technology, Incorporated

March 7, 2007
March 8, 2007
July 27, 2017
July 2005
Not Provided
  • 1 - Safety
  • 2 - Viral Load measure (blood and intracellular)
  • 3 - CD4/CD8 levels
Same as current
Complete list of historical versions of study NCT00444847 on ClinicalTrials.gov Archive Site
ADL measurements
Same as current
Not Provided
Not Provided
Effect of Repeated Exposures to Compressed Air on Patients With AIDS
Effect of Repeated Exposure to Compressed Air on Patients With AIDS (Acquired Immunodeficiency Syndrome)
The exposure of human beings to markedly altered environments (ambient pressure and inhaled gas mixtures) has profound effects on their innate immune capacity to effectively combat viral illnesses. This Phase IIA clinical trial examines the effects of an exposure to a 4 atmospheric environment has on HIV-infected humans whose clinical condition has progressed to formal AIDS status.
Not Provided
Phase 2
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: Single
Primary Purpose: Treatment
Device: Hyperbaric chamber
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Not Provided
Not Provided

Inclusion Criteria:

  • CD4 count <200
  • Viral load > 5000

Exclusion Criteria:

  • Opportunistic infection
  • Concurrent neoplasm (see protocol)
  • Immunomodulators
  • HIV vaccination
  • Investigational HIV drugs (see protocol)
  • Pregnant women
  • Major organ transplant
Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
United States
DANET HIV/AIDS Trial Q050021
FDA Q050021
Not Provided
Not Provided
Not Provided
Designed Altobaric Technology, Incorporated
Not Provided
Principal Investigator: Stephen D. Guthrie, MD, PhD Designed Altobaric Environment Technology
Principal Investigator: Stephen G Guthrie, MD, PhD Designed Altobaric Environment Technology
Designed Altobaric Technology, Incorporated
March 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP